Related content

Nonmyeloablative conditioning to induce bilateral tolerance after allogeneic bone marrow transplantation in mice - an overview

By Prigozhina T.B.   Gurevitch O.   Slavin S.  

Experimental Hematology, Vol. 27, Iss. 10, 1999-10 ,pp. : 1503-1510

Elsevier

Access to resources Recommend Favorite

Nonmyeloablative allogeneic bone marrow transplantation as immunotherapy for hematologic malignancies and metastatic solid tumors in preclinical models

By Prigozhina T.B.   Gurevitch O.   Morecki S.   Yakovlev E.   Elkin G.   Slavin S.  

Experimental Hematology, Vol. 30, Iss. 1, 2002-01 ,pp. : 89-96

Elsevier

Access to resources Recommend Favorite

Hematologically Important Mutations: Glanzmann Thrombasthenia

By French D.L.   Coller B.S.  

Blood Cells, Molecules, and Diseases, Vol. 23, Iss. 1, 1997-04 ,pp. : 39-51

Academic Press

Access to resources Recommend Favorite

Early host CD8 T-cell recovery and sensitized anti-donor interleukin-2-producing and cytotoxic T-cell responses associated with marrow graft rejection following nonmyeloablative allogeneic bone marrow transplantation

By Kraus A.B.   Shaffer J.   Toh H.C.   Preffer F.   Dombkowski D.   Saidman S.   Colby C.   George R.   McAfee S.   Sackstein R.   Dey B.   Spitzer T.R.   Sykes M.  

Experimental Hematology, Vol. 31, Iss. 7, 2003-07 ,pp. : 609-621

Elsevier

Access to resources Recommend Favorite

Understanding the genetic basis of Glanzmann thrombasthenia: implications for treatment

By Nurden Alan T   Pillois Xavier   Nurden Paquita  

Expert Review of Hematology, Vol. 5, Iss. 5, 2012-10 ,pp. : 487-503

Informa Healthcare

Access to resources Recommend Favorite